Senzime AB (SE0002478776) — research page
SE · se-cm-kg/XSTO/SE0002478776 · as of 2026-11-06
Identity and listing
The issuer is Senzime AB, listed on Nasdaq Stockholm under ticker SE0002478776, with ISIN SE0002478776 and LEI 549300JQF174JP0MM382. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Senzime AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0002478776 | source · 2026-11-06 |
| ISIN | SE0002478776 | source · 2026-11-06 |
| LEI | 549300JQF174JP0MM382 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 35 filings in the twelve months to 2026-11-06, on 32 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type Investor News, 1 day before the record date. The exchange median is 9.5 days of cadence gap, 30.0 filings and 7.0 days of latency across 398 issuers on Nasdaq Stockholm. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 35 | 7 | 1 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | Investor News | Investor News | Senzime Expands TetraGraph's Clinical Use Beyond Surgery into Brain Stimulation Therapy |
| 2026-10-29 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Senzime Q3 2026: Continued strong sensor sales and growth in all regions. Clear progress towards profitability. |
| 2026-10-26 | Investor News | Investor News | Invitation to presentations of Senzime's third quarter 2026 report |
| 2026-10-17 | Investor News | Investor News | New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular Monitoring |
| 2026-10-13 | Investor News | Investor News | Senzime Launches Industry-First Predictive Neuromuscular Monitoring Technology |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.
Events and halts
The record carries no delisting, domicile change, listing, name change or segment move for the issuer, as the market has no lifecycle type map for this register. The halt flag is not set, and the issuer is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
Two research houses are named on the issuer's investor-relations page: Redeye and Carnegie. The count is 2.
| research house | analyst | source · read date |
|---|---|---|
| Redeye | Gustaf Meyer | issuer page · 2026-11-12 |
| Carnegie | Klas Palin | issuer page · 2026-11-12 |
Open research
Four openly published research notes are on the record: Redeye on 2025-09-04, Carnegie Securities Research on 2025-04-23, Carnegie Securities Research on 2025-03-14, and Redeye on 2024-09-16.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-09-04 | Redeye | Senzime | independent |
| 2025-04-23 | Carnegie Securities Research | Senzime | issuer-sponsored |
| 2025-03-14 | Carnegie Securities Research | Senzime | issuer-sponsored |
| 2024-09-16 | Redeye | Monitoring growth | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No years are sealed for the issuer, the market's earliest sealed date is not on the record, and the live record's start date is not on the record.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0002478776 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.senzime.com/en/analysts (coverage)
- 10.7
- https://www.senzime.com/sites/default/files/files/senzime-monitoring-a-growth-story-in-progress%20-%202025-09-04.pdf (open research)
- 10.8
- https://www.senzime.com/sites/default/files/files/senzime_250423.pdf (open research)
- 10.9
- https://www.senzime.com/sites/default/files/files/senzime_250314.pdf (open research)
- 10.10
- https://www.senzime.com/sites/default/files/files/senzime160924.pdf (open research)
- 10.11
- https://mcp.se-cm-kg.ai/record/XSTO/SE0002478776 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0002478776"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:ae7f5a87865551d7.